180 related articles for article (PubMed ID: 11809281)
1. Recruitment of women into trials.
Benson JR
Lancet; 2002 Jan; 359(9301):164. PubMed ID: 11809281
[No Abstract] [Full Text] [Related]
2. STAR: first-year recruitment efforts set brisk pace for future.
CA Cancer J Clin; 2000; 50(5):271-2. PubMed ID: 11075236
[No Abstract] [Full Text] [Related]
3. Chemoprevention of breast cancer.
Zelnak AB; O'Regan RM
Curr Probl Cancer; 2004; 28(4):201-17. PubMed ID: 15318323
[No Abstract] [Full Text] [Related]
4. The role of selective estrogen receptor modulators in the prevention of breast cancer: comparison of the clinical trials.
Martino S; Costantino J; McNabb M; Mershon J; Bryant K; Powles T; Secrest RJ
Oncologist; 2004; 9(2):116-25. PubMed ID: 15047916
[TBL] [Abstract][Full Text] [Related]
5. Breast Cancer Risk-Reducing Medications.
Graham D; DiNome ML; Ganz PA
JAMA; 2020 Jul; 324(3):310. PubMed ID: 32692388
[No Abstract] [Full Text] [Related]
6. Medications for Primary Prevention of Breast Cancer.
Shieh Y; Tice JA
JAMA; 2020 Jul; 324(3):291-292. PubMed ID: 32692377
[No Abstract] [Full Text] [Related]
7. Breast cancer prevention in high-risk women: searching for new options.
Nelson NJ
J Natl Cancer Inst; 2011 May; 103(9):710-1. PubMed ID: 21515834
[No Abstract] [Full Text] [Related]
8. Tamoxifen prevention of breast cancer: an instance of the fingerpost.
Lippman SM; Brown PH
J Natl Cancer Inst; 1999 Nov; 91(21):1809-19. PubMed ID: 10547388
[No Abstract] [Full Text] [Related]
9. Breast cancer chemoprevention: current status and future directions.
Wickerham DL; Tan-Chiu E
Semin Oncol; 2001 Jun; 28(3):253-9. PubMed ID: 11402435
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention of breast cancer: recommendations and rationale.
U.S. Preventive Services Task Force
Ann Intern Med; 2002 Jul; 137(1):56-8. PubMed ID: 12093249
[No Abstract] [Full Text] [Related]
11. Raloxifene in breast cancer prevention.
Gennari L; Merlotti D; Paola VD; Nuti R
Expert Opin Drug Saf; 2008 May; 7(3):259-70. PubMed ID: 18462184
[TBL] [Abstract][Full Text] [Related]
12. Raloxifene examined for breast cancer prevention.
Young D
Am J Health Syst Pharm; 2007 Sep; 64(17):1774. PubMed ID: 17724350
[No Abstract] [Full Text] [Related]
13. Breast cancer chemoprevention: A service in need of menopause specialist support.
Marsden J
Post Reprod Health; 2017 Mar; 23(1):15-21. PubMed ID: 28081658
[No Abstract] [Full Text] [Related]
14. Selective estrogen receptor modulators and prevention of invasive breast cancer.
Gradishar WJ; Cella D
JAMA; 2006 Jun; 295(23):2784-6. PubMed ID: 16754726
[No Abstract] [Full Text] [Related]
15. Raloxifene vs tamoxifen.
Goldstein SR
JAMA; 2007 Jan; 297(3):263-4; author reply 264. PubMed ID: 17227974
[No Abstract] [Full Text] [Related]
16. Women's interest in taking tamoxifen and raloxifene for breast cancer prevention: response to a tailored decision aid.
Fagerlin A; Dillard AJ; Smith DM; Zikmund-Fisher BJ; Pitsch R; McClure JB; Greene S; Alford SH; Nair V; Hayes DF; Wiese C; Ubel PA
Breast Cancer Res Treat; 2011 Jun; 127(3):681-8. PubMed ID: 21442198
[TBL] [Abstract][Full Text] [Related]
17. Summaries for patients. Using medication to prevent breast cancer: recommendations from the United States Preventive Services Task Force.
Ann Intern Med; 2002 Jul; 137(1):I62. PubMed ID: 12093267
[No Abstract] [Full Text] [Related]
18. Chemoprevention with antiestrogens: the beginning of the end for breast cancer. Daniel G. Miller Lecture.
Jordan VC
Ann N Y Acad Sci; 2001 Dec; 952():60-72. PubMed ID: 11795444
[TBL] [Abstract][Full Text] [Related]
19. Endocrine prevention of breast cancer using selective oestrogen receptor modulators (SORMs).
Lo SS; Vogel VG
Best Pract Res Clin Endocrinol Metab; 2004 Mar; 18(1):97-111. PubMed ID: 14687600
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer prevention.
Rodabaugh KJ; Bloss JD
Clin Obstet Gynecol; 2001 Sep; 44(3):478-84. PubMed ID: 11685873
[No Abstract] [Full Text] [Related]
[Next] [New Search]
